PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
275.14
Positive P/E while Healthcare median is negative at -1.87. Peter Lynch would investigate competitive advantages in a distressed Healthcare.
146.57
P/S exceeding 1.5x Healthcare median of 11.30. Jim Chanos would check for potential multiple compression risks.
10.78
P/B exceeding 1.5x Healthcare median of 3.05. Jim Chanos would check for potential asset write-down risks.
-322.31
Negative FCF while Healthcare median P/FCF is -7.06. Seth Klarman would investigate cash flow improvement potential.
-1022.02
Negative operating cash flow while Healthcare median P/OCF is -4.49. Seth Klarman would investigate operational improvement potential.
10.78
Fair value ratio exceeding 1.5x Healthcare median of 3.05. Jim Chanos would check for valuation bubble risks.
0.09%
Positive earnings while Healthcare median shows losses. Peter Lynch would examine earnings quality advantage.
-0.31%
Negative FCF while Healthcare median yield is -0.32%. Seth Klarman would investigate cash flow improvement potential.